Brilacidin
Also known as: PMX-30063, Brilacidin tetrahydrochloride
Brilacidin is an investigational small-molecule defensin mimic, not a true peptide. Antimicrobial and anti-inflammatory mechanisms are supported largely by laboratory work; company-reported Phase 2 findings have not established peer-reviewed controlled human efficacy.
Quick Facts
What is brilacidin?
Brilacidin tetrahydrochloride was developed by Innovation Pharmaceuticals as PMX-30063. It mimics host-defense peptides called defensins, but is chemically a small-molecule peptidomimetic. Research includes oral-mucositis mouth rinses and antibacterial or antiviral applications. No use is approved.
How does it work?
Its charge pattern is proposed to disrupt bacterial and fungal membranes. Cell studies against SARS-CoV-2 report viral disruption and interference with entry into host cells. Anti-inflammatory activity is also proposed for oral mucositis. These mechanisms, observed chiefly in laboratory systems, do not establish patient benefit.
Is it FDA-approved?
Brilacidin remains investigational without an approved indication. Progress has depended on funding and partnerships, and a completed confirmatory Phase 3 program has not been reported.
What does the research show?
| Evidence | Finding | Publication boundary |
|---|---|---|
| Oral-mucositis Phase 2 | Company described positive topline results | No peer-reviewed efficacy report in the cited material |
| COVID-19 Phase 2 | Company described positive topline results | No peer-reviewed efficacy report in the cited material |
| SARS-CoV-2 cell study | Inhibition in culture | Peer reviewed |
| Coronavirus laboratory study | Broad antiviral activity | Peer reviewed |
Press-release findings and published laboratory activity are different evidence types. Clinical efficacy remains unestablished without peer-reviewed controlled human results.
References and further reading
This reference draws on Superpower’s Peptide Library and the research linked below. Peptide Dossier’s editorial team adapted and integrated the material on .
- 10.3390/v13020271What does the research show?Cited in: What does the research show?
- 10.1002/jmv.27616What does the research show?Cited in: What does the research show?
Frequently Asked Questions About Brilacidin
Related Peptides
Continue exploring Brilacidin
Search all related references →Our library review is ongoing. Read how we evaluate evidence or report a correction.
Disclaimer: This article is for informational and educational purposes only. It is not intended as medical advice. The information presented is based on published research and should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting any peptide protocol. Some peptides discussed may not be approved for human use by the FDA or equivalent regulatory bodies.